ASCO 2009: Bevacizumab and standard adjuvant chemotherapy: no improvement in dis...
Steven K. Cheng, phd - Oregon Health and Science University, Oregan, USA. ASCO p...
Dr. Vincent O. Dezentjé - Leiden University Medical Center, Leiden, The Netherl...
Eric Van Cutsem, MD, phd, University Hospital Gasthuisberg, Leuven, Belgium, spe...
ASCO 2009: Rowan T. Chlebowski, MD, phd - Harbor-UCLA Medical Center - Los Angel...
ecancertv |
(0) (0 Votes)
|
Views: (706) Date: (07-04-10) Time: (00:04:46) |
Description: Dr. Vincent O. Dezentjé - Leiden University Medical Center, Leiden, The Netherlands ASCO press conference: Two studies report differing results about whether the antidepressants, fluoxetine and paroxetine, have an adverse impact on the effectiveness of tamoxifen.